David Gionco, Chief Accounting Officer at STEMLINE THERAPEUTICS INC (STML), sold 6,486 shares at $7.01 ($45K) on 2017-02-28, disclosed to the SEC on 2017-03-01.
Open-market sale of $45k STML by Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.97 | 3,500 | $24K | 53.8% |
| 2 | $7.01 | 2,986 | $21K | 46.2% |
| Total | $6.99 avg | 6,486 | $45K | 100% |
| Filing → |
| STML | SELL | 2020-03-13 | $69K | — | Filing → |
| STML | SELL | 2020-02-28 | $118K | — | Filing → |
| STML | SELL | 2020-01-03 | $49K | — | Filing → |